| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.041200934 |
Resistant |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.042888303 |
Resistant |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044443119 |
Resistant |
